This Article Full Text Full Text (PDF) Other Versions of this Article: JVI.02400-07v1 82/9/4562    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Google Scholar Articles by Santarelli, R. Articles by Faggioni, A. PubMed PubMed Citation Articles by Santarelli, R. Articles by Faggioni, A.

 Previous Article  |  Next Article 

Journal of Virology, May 2008, p. 4562-4572, Vol. 82, No. 9
0022-538X/08/$08.00+0     doi:10.1128/JVI.02400-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Identification and Characterization of the Product Encoded by ORF69 of Kaposi's Sarcoma-Associated Herpesvirus

Istituto Pasteur Fondazione Cenci-Bolognetti, Dipartimento di Medicina Sperimentale, Università di Roma "La Sapienza," Rome, Italy,¹ Azienda Ospedaliera Sant'Andrea, Rome, Italy,² Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università Tor Vergata, Rome, Italy³

Received 7 November 2007/ Accepted 19 February 2008

We report the identification and characterization of p33, the product of Kaposi's sarcoma-associated herpesvirus (KSHV) open reading frame 69 (ORF69), a positional homolog of the conserved herpesvirus protein UL31. p33 is expressed upon induction of viral lytic cycle with early kinetics. Immunofluorescence analysis revealed that in infected cell lines, the protein is localized in the nucleus, both in dotted spots and along the nuclear membrane. Nuclear fractionation experiments showed that p33 partitions with the nuclear matrix, and both immunoblotting of purified virions and immunoelectron microscopy indicated that the novel protein is not a component of the mature virus. Following ectopic expression in KSHV-negative cells, the protein was never associated with the nuclear membrane, suggesting that p33 needs to interact with additional viral proteins to reach the nuclear rim. In fact, after cotransfection with the ORF67 gene, the KSHV positional homolog of UL34, the p33 intranuclear signal changed and the two proteins colocalized on the nuclear membrane. A similar result was obtained when ORF69 was cotransfected with BFRF1, the Epstein-Barr virus (EBV) positional homolog of UL34 and ORF67. Finally, upon cotransfection, ORF69 significantly increased nuclear membrane reduplications induced by BFRF1. The above results indicate that KSHV p33 shares many similarities with its EBV homolog BFLF2 and suggest that functional cross-complementation is possible between members of the gammaherpesvirus subfamily.

Published ahead of print on 27 February 2008.